Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Oceania Healthcare Ltd

Healthcare AU OCA

0.625AUD
-0.005(0.79%)

Last update at 2025-07-02T05:45:00Z

Day Range

0.620.64
LowHigh

52 Week Range

0.470.80
LowHigh

Fundamentals

  • Previous Close 0.63
  • Market Cap442.46M
  • Volume11029
  • P/E Ratio13.50
  • Dividend Yield-%
  • EBITDA-2.34000M
  • Revenue TTM260.57M
  • Revenue Per Share TTM0.36
  • Gross Profit TTM 82.20M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Income before tax 12.00M 56.25M 75.14M 31.80M 75.88M
Minority interest - - - - -
Net income 15.45M 61.13M 85.53M 45.37M 76.97M
Selling general administrative 164.64M 158.94M 115.69M 127.33M 122.36M
Selling and marketing expenses - - - - -
Gross profit 247.18M 231.14M - 186.98M 180.05M
Reconciled depreciation 17.92M 18.62M - 14.49M 9.54M
Ebit 35.44M 70.39M -4.01280M 49.98M 77.58M
Ebitda 53.36M 89.01M - 59.52M 86.42M
Depreciation and amortization 17.92M 18.62M - 9.54M 8.84M
Non operating income net other - - - - -
Operating income 35.44M 70.39M 3.67M -20.29800M 2.38M
Other operating expenses 247.62M 236.72M 56.91M 213.94M 184.60M
Interest expense 13.87M 8.85M 0.00000M 3.00M 2.94M
Tax provision -3.44800M -4.87900M -10.39600M -14.66600M -13.57600M
Interest income 1.76M 0.08M 73.68M 28.92M 43.33M
Net interest income -12.55600M -9.30300M - -5.10600M -2.85200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.44800M -4.87900M -12.47520M -13.57600M -1.09600M
Total revenue 247.18M 231.14M 175.42M 186.98M 180.05M
Total operating expenses 247.62M 236.72M - 184.60M 151.43M
Cost of revenue - - - - 123.75M
Total other income expense net -23.43900M -14.14100M - 32.91M 50.03M
Discontinued operations - - - - -
Net income from continuing ops 15.45M 61.13M - -13.64200M 45.37M
Net income applicable to common shares 15.45M 61.13M 102.82M -13.64200M 45.37M
Preferred stock and other adjustments - - - - -
Breakdown 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Type yearly yearly yearly yearly yearly
Date 2025-05-31 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Total assets 2940.69M 2782.35M 2544.94M 2197.69M 1883.73M
Intangible assets - 2.78M 3.55M 3.67M 5.23M
Earning assets - - - - -
Other current assets - 44.26M 101.65M 6.61M 2.00M
Total liab - 1755.89M 1582.68M 1248.85M 1048.53M
Total stockholder equity - 1026.46M 962.26M 948.84M 835.20M
Deferred long term liab - - - - -
Other current liab - 1004.77M 969.17M 814.70M 623.78M
Common stock - 715.96M 713.37M 705.29M 675.62M
Capital stock - 715.96M 713.37M 705.29M -
Retained earnings - -34.26400M -68.49600M -54.73500M -86.98300M
Other liab - - 66.87M 65.07M 60.12M
Good will - 2.88M 3.17M 4.93M 5.34M
Other assets - - 1597.72M 1378.55M 1099.80M
Cash - 7.49M 7.44M 9.74M 79.91M
Cash and equivalents - - - - -
Total current liabilities - 1104.17M 1024.29M 858.81M 647.22M
Current deferred revenue - 47.34M 45.33M 42.07M -
Net debt - 644.24M 550.95M 380.29M -
Short term debt - 37.08M - - -
Short long term debt - - - - -
Short long term debt total - 651.72M 558.39M 390.03M 327.29M
Other stockholder equity - - 317.38M 298.29M 244.98M
Property plant equipment - - 716.46M 727.73M 645.99M
Total current assets - 179.64M 224.05M 82.80M 127.90M
Long term investments - 1815.39M 1597.72M 1378.55M -
Net tangible assets - - 955.54M 940.24M 825.16M
Short term investments - - - - -
Net receivables - 120.03M 106.47M 66.45M 43.10M
Long term debt - 640.52M 553.59M 380.14M 327.29M
Inventory - 0.00000M - - -
Accounts payable - 14.97M 9.79M 2.04M 9.30M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 344.76M 317.38M 298.29M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 1818.42M - - -
Deferred long term asset charges - - - - -
Non current assets total - 2602.71M 2320.89M 2114.89M -
Capital lease obligations - 11.21M 4.80M 9.89M -
Long term debt total - - - - 327.29M
Breakdown 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Type yearly yearly yearly yearly yearly
Date 2023-05-31 2022-05-31 2021-05-31 2020-05-31 2019-05-31
Investments -219.60100M -218.82000M - -135.98300M -153.77400M
Change to liabilities 11.33M -1.75700M 7.29M 0.09M 4.69M
Total cashflows from investing activities -219.60100M -218.82000M -122.62800M -135.98300M -153.77400M
Net borrowings 171.07M 44.22M -1.65600M 54.31M 96.68M
Total cash from financing activities 147.09M 43.13M 82.22M 31.48M 56.59M
Change to operating activities - - - - -
Net income 15.45M 61.13M 102.82M -13.64200M 45.37M
Change in cash -2.30600M -70.16100M 74.74M -5.13800M 7.43M
Begin period cash flow 9.74M 79.91M 17.62M 22.76M 10.86M
End period cash flow 7.44M 9.74M 79.91M 17.62M 18.29M
Total cash from operating activities 15.45M 18.62M 115.14M 99.37M 89.32M
Issuance of capital stock - 20.00M - - 1.30M
Depreciation 17.27M 18.62M 16.03M 14.49M 9.54M
Other cashflows from investing activities - - -66.00500M -95.51600M -80.87900M
Dividends paid -21.80600M -19.41800M 7.56M -22.22700M -12.73200M
Change to inventory - - - - -
Change to account receivables 5.64M 13.11M -2.72520M -2.59500M 0.29M
Sale purchase of stock - - - 1.30M 1.30M
Other cashflows from financing activities 223.19M 158.02M -4.56000M 166.33M 117.20M
Change to netincome 19.86M 14.43M -8.47920M 101.02M 29.42M
Capital expenditures 55.16M 56.29M 43.42M 40.43M 33.39M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - -56.24800M -59.42400M -44.91200M
Stock based compensation - - - - -
Other non cash items -15.44800M -79.74900M - -0.85000M -54.91500M
Free cash flow -39.71200M -37.66900M - -40.43300M -33.38900M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OCA
Oceania Healthcare Ltd		 -0.005 0.79% 0.62 13.50 - 1.70 0.38 4.25 16.29
RHCPA
Ramsay Health Care Ltd Pref		 -0.44 0.41% 105.90 65.18 - 0.84 -
RHC
Ramsay Health Care Ltd		 0.92 2.45% 38.45 452.50 24.69 0.49 1.81 1.14 14.17
SNZ
Summerset Group Holdings Ltd		 0.68 6.79% 10.70 7.62 5.25 7.77 0.89 13.76 10.94
REG
Regis Healthcare Ltd		 -0.1 1.32% 7.50 152.20 34.01 2.09 259.34 2.07 9.70

Reports Covered

Stock Research & News

View All

Profile

Oceania Healthcare Limited, together with its subsidiaries, owns and operates retirement villages and care centres in New Zealand. It operates through three segments: Care Operations, Village Operations, and Other. The company offers traditional care beds and care suites; independent living and rental properties; and rest home, hospital, and specialist dementia services. It also provides accommodation, and care and related services to aged care residents; and accommodation and related services to independent residents in the retirement villages. In addition, the company is involved in the provision of support services and training activities. The company was formerly known as Retirement Care (NZ) Limited and changed its name to Oceania Healthcare Limited in September 2014. Oceania Healthcare Limited was incorporated in 2005 and is based in Auckland, New Zealand.

Oceania Healthcare Ltd

HSBC Tower, Auckland, New Zealand, 1010

Key Executives

Name Title Year Born
Mr. Brent Pattison BBS, C.A. Chief Exec. Officer NA
Ms. Kathryn Waugh Chief Financial Officer NA
Anita Hawthorne B.Com., C.A. Group Gen. Mang. of Sales & Services NA
Dr. Frances Hughes Gen. Mang. - Nursing & Clinical Strategy NA
Eli Parkin Head of Devel. NA
Mr. Brent Pattison BBS, C.A. Chief Executive Officer NA
Anita Hawthorne B.Com., C.A. Group General Manager of Sales & Services NA
Eli Parkin Head of Development NA
Mr. Brent Pattison BBS, C.A. Chief Executive Officer NA
Anita Hawthorne B.Com., C.A. Group General Manager of Sales & Services NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.